Who owns Sagimet Biosciences Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of SGMT from SEC Form 13F filings across 153 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 153 institutions disclosed 69.7M shares of Sagimet Biosciences Inc. worth $688.6M — about 111.8% of shares outstanding; the largest disclosed holder is BlackRock, Inc.. Source: SEC Form 13F filings, parsed by EvidInvest.
153
13F holders
$688.6M
value, 2026 filers
111.8%
of shares outstanding (69.7M sh)
53
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of SGMT's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 7.0M | $68.9M | 0.0% | 11.2% | +6.0% |
| 2 | Balyasny Asset Management L.P. | 5.5M | $54.8M | 0.1% | 8.9% | +52.8% |
| 3 | SILVERARC CAPITAL MANAGEMENT, LLC | 3.7M | $37.0M | 4.3% | 6% | +28.0% |
| 4 | BVF INC/IL | 3.5M | $34.6M | 1.1% | 5.6% | +40.0% |
| 5 | Woodline Partners LP | 3.1M | $31.1M | 0.1% | 5% | +4.8% |
| 6 | FEDERATED HERMES, INC. | 3.1M | $30.6M | 0.0% | 5% | +48.3% |
| 7 | Caligan Partners LP | 2.8M | $27.6M | 1.7% | 4.5% | +11.8% |
| 8 | Commodore Capital LPNEW | 2.8M | $27.2M | 2.1% | 4.4% | new |
| 9 | VANGUARD CAPITAL MANAGEMENT LLC | 2.6M | $26.0M | 0.0% | 4.2% | +2.3% |
| 10 | Affinity Asset Advisors, LLC | 2.5M | $25.0M | 1.0% | 4.1% | +1.2% |
| 11 | STATE STREET CORP | 2.4M | $24.0M | 0.0% | 3.9% | +21.7% |
| 12 | Saturn V Capital Management LP | 2.0M | $19.8M | 2.9% | 3.2% | +35.3% |
| 13 | GREAT POINT PARTNERS LLC | 2.0M | $19.4M | 4.6% | 3.1% | -3.4% |
| 14 | AMERIPRISE FINANCIAL INC | 1.9M | $18.8M | 0.0% | 3% | +227.0% |
| 15 | RA CAPITAL MANAGEMENT, L.P.NEW | 1.8M | $17.8M | 0.2% | 2.9% | new |
| 16 | GEODE CAPITAL MANAGEMENT, LLC | 1.5M | $15.3M | 0.0% | 2.5% | +6.9% |
| 17 | Aberdeen Group plc | 1.5M | $14.6M | 0.0% | 2.4% | +74.0% |
| 18 | Spruce Street Capital LPNEW | 1.4M | $13.8M | 2.2% | 2.2% | new |
| 19 | Blue Owl Capital Holdings LP | 1.1M | $11.1M | 2.0% | 1.8% | -10.7% |
| 20 | ADAGE CAPITAL PARTNERS GP, L.L.C.NEW | 1.1M | $11.0M | 0.0% | 1.8% | new |
| 21 | D. E. Shaw & Co., Inc. | 1.0M | $10.3M | 0.0% | 1.7% | +4579.2% |
| 22 | MARSHALL WACE, LLPNEW | 752,365 | $7.4M | 0.0% | 1.2% | new |
| 23 | Driehaus Capital Management LLC | 727,150 | $7.2M | 0.0% | 1.2% | +336.3% |
| 24 | Atom Investors LP | 725,924 | $7.2M | 0.4% | 1.2% | +109.8% |
| 25 | GOLDMAN SACHS GROUP INC | 568,526 | $5.6M | 0.0% | 0.9% | -25.1% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.